About Santiago Life Sciences Private Limited
Data last updated:
Santiago Life Sciences Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2016PTC035265. Its GSTIN is 23AAWCS6649G1ZR (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ankur Budhrani and Durga Prasad Budhrani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 3 Satkar Bhawan Near Clock Tower Badi Omti Jabalpur, Madhya Pradesh, India – 482001.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.88 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹18.81 Lakh (net margin 1%) and EBITDA of ₹67.17 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹45 Lakh on record. Court records list 9 cases involving the company, including 6 filed by the company and 3 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website santiagolifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address2 – 3 Satkar Bhawan Near Clock Tower Badi Omti Jabalpur, Madhya Pradesh, India – 482001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Santiago Life Sciences Private Limited
The main business activity of Santiago Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Santiago Life Sciences Private Limited FY 2025 filings available
Santiago Life Sciences Private Limited reported revenue of ₹18.88 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Santiago Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 5% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Santiago Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹67.17 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Santiago Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Santiago Life Sciences are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Santiago Life Sciences Private Limited
Santiago Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tablets Medopharm Private Limited | ₹18.97 Cr (FY 2025) | •••• | •••• | 63.0% | •••• | Chennai, Tamil Nadu, India |
| TVB Healthcare Private Limited | ₹18.97 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Delhi, India |
| Vasudha Life Science Private Limited | ₹18.95 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Brahmavara, Karnataka, India |
| Isera Biological Limited | ₹18.94 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Pune, Maharashtra, India |
| Kee Pharma Limited | ₹18.89 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | New Delhi, Delhi, India |
| Santiago Life Sciences Private Limited this company | ₹18.88 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Bayberry Pharmaceuticals Private Limited | ₹18.82 Cr (FY 2025) | •••• | •••• | 301.0% | •••• | Pune, Maharashtra, India |
| Sunwin Healthcare Private Limited | ₹18.79 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Panchkula, Haryana, India |
| Indu Drugs Private Limited | ₹18.78 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Gulkas Pharma Pvt Ltd | ₹18.78 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Kalol, Gujarat, India |
| Anaesthetic Gases Pvt Ltd | ₹18.78 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Santiago Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Santiago Life Sciences Private Limited
Santiago Life Sciences Private Limited is audited by ARUN GROVER & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARUN GROVER & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Santiago Life Sciences Private Limited
Santiago Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankur Budhrani | Director | 22 Jan 2016 | 10 Years 8 Months | Current |
| Durga Prasad Budhrani Also directs: Arico Healthcare LLP, Real Water Fun Private Limited | Director | 22 Jan 2016 | 10 Years 8 Months | Current |
| Shubham Budhrani | Director | 22 Jan 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of Santiago Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Santiago Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2022 | Hdfc Bank Limited | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Santiago Life Sciences Private Limited
Santiago Life Sciences Private Limited has 9 court cases on record: 6 filed by Santiago Life Sciences, 3 filed against it. 1 case is pending and 8 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 0 |
| High courts | 4 | 3 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Bharat Serums and Vaccines Limited | Disposed |
| High Court of Madhya Pradesh | Writ petition | Filed by the company against Union of India | Pending |
| District court, Jabalpur, Madhya Pradesh | Court case (UN CR) | Filed by the company against an individual | Disposed |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Santiago Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Santiago Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Santiago Life Sciences Private Limited
Santiago Life Sciences Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Ankur Budhrani was appointed as Director on 22 Jan 2016.
Credit Ratings, Litigation & Regulatory Alerts for Santiago Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Santiago Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Santiago Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Santiago Life Sciences Private Limited
Santiago Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAWCS6649G1ZR | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Santiago Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santiago Life Sciences Private Limited
Santiago Life Sciences is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 January 2016 (10+ years old) and is registered under CIN U24100MP2016PTC035265.
Santiago Life Sciences reported revenue of ₹18.88 Cr for FY 2024 (up 5% YoY).
Santiago Life Sciences has 3 current directors:
- Ankur Budhrani - Director
- Durga Prasad Budhrani - Director
- Shubham Budhrani - Director
Santiago Life Sciences reported a net profit of ₹18.81 Lakh (net margin 1%) and EBITDA of ₹67.17 Lakh (EBITDA margin 3.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Santiago Life Sciences is 7% over three years and 10% over five years. In the latest year (FY 2024) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Santiago Life Sciences is 23AAWCS6649G1ZR, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Santiago Life Sciences is U24100MP2016PTC035265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Santiago Life Sciences has 9 court cases on record: 6 filed by the company and 3 filed against it. 1 is pending. Most are in the district courts.
Santiago Life Sciences was incorporated on 22 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Santiago Life Sciences by revenue are Tablets Medopharm Private Limited, TVB Healthcare Private Limited, Vasudha Life Science Private Limited, Isera Biological Limited, Kee Pharma Limited and 5 more, all in the Pharma industry (Formulations).
Ankur Budhrani was appointed as Director on 22 Jan 2016. Durga Prasad Budhrani was appointed as Director on 22 Jan 2016. Shubham Budhrani was appointed as Director on 22 Jan 2016.